Tuesday, 1 August 2017

Europe Intramedullary Hip Nails Marker Report Review, 2017

Europe Market Report for Intramedullary Hip Nails 2017 - MedCore is a new market research publication announced by Reportstack.
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
IM hip screws are more expensive but favored by doctors because of the mechanical strength of the repair system over sliding plates and conventional hip screws. There is a decreased amount of operative blood loss and, accordingly, a shorter hospital treatment. They are best used for highly comminuted fractures of the greater trochanter.
Disadvantages include greater thigh pain and longer surgical procedure times. Additionally, the fractured limb must be reduced prior to the insertion of the intramedullary device.
To access full report with TOC, please visit ​Europe Market Report for Intramedullary Hip Nails 2017 - MedCore.

Companies Mentioned
DePuy Synthes Stryker Zimmer Biomet Smith and Nephew Orthofix Bioventus Biomedical Tissue Technologies DJO Global Igea Acumed Wright Medical Konigsee Medartis Axomed Aap Mmplantate Aesculap Arthrex Others include: Aap Implantate AG, Acute Innovations, Advanced Orthopedic Solutions, BioPro, CarbonFix Orthopedics, Cardinal Health, Citieffe, ConMed, Covision Orthopedics, Evolutis, FH Orthopedics, Greatbatch Medical, Gruppo Bioimpianti, Inion, Intrauma, Lima Corporate, Link Orthopaedics, Medartis, Merete Medical, N-Dis, Ortomedic, TREU-Instrumente GmbH, Waldemar Link etc.
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research

No comments:

Post a Comment